World's cheapest Indian tablet

World's cheapest Indian tablet

NEW DELHI, India - A student holds on Oct. 5, 2011 in New Delhi a tablet computer, nicknamed Aakash, which was unveiled and launched in the Indian capital by the government the same day. Aakash, which has been designed, developed and manufactured by the Britain-based DataWind Ltd. in association with the Indian Institute of Technology in Rajasthan under the Indian government's National Mission on Education through Information and Technology (NME-ICT), will carry a price as low as $38, making it the world's cheapest tablet computer. (Kyodo)

  • Product Code
  • ILEA000326231
  • Registered date
  • 2011/10/06 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1889 × 1205 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 721.59(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Daily Life In Warsaw

    Daily Life In Warsaw

    WARSAW, POLAND - NOVEMBER 19: The Palace of Culture and Science in Warsaw on a cold November day, on November 19, 2024 in Warsaw, Poland. (Photo by Artur Widak/NurPhoto)
      Daily Life In Warsaw

      Daily Life In Warsaw

      WARSAW, POLAND - NOVEMBER 19: The Palace of Culture and Science in Warsaw on a cold November day, on November 19, 2024 in Warsaw, Poland. (Photo by Artur Widak/NurPhoto)
        Daily Life In Warsaw

        Daily Life In Warsaw

        WARSAW, POLAND - NOVEMBER 19: The Palace of Culture and Science in Warsaw on a cold November day, on November 19, 2024 in Warsaw, Poland. (Photo by Artur Widak/NurPhoto)
          Daily Life In Warsaw

          Daily Life In Warsaw

          WARSAW, POLAND - NOVEMBER 19: The Palace of Culture and Science in Warsaw on a cold November day, on November 19, 2024 in Warsaw, Poland. (Photo by Artur Widak/NurPhoto)
            Daily Life In Warsaw

            Daily Life In Warsaw

            WARSAW, POLAND - NOVEMBER 19: The Palace of Culture and Science in Warsaw on a cold November day, on November 19, 2024 in Warsaw, Poland. (Photo by Artur Widak/NurPhoto)
              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                    Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                    BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                      Tolls Generate 3.6 Million Euros Per Day For Concessionaires

                      Tolls Generate 3.6 Million Euros Per Day For Concessionaires

                      Cars drive near a toll at the 25 de Abril bridge in Lisbon, Portugal, on September 29, 2024. Data from the Portuguese Association of Highway Concessionaire Companies (APCAP) shows that the highway network length remains unchanged last year (3,321.9 kilometers). However, average daily traffic increases again, generating an average of about 3.6 million euros per day. The largest share of this revenue belongs to Brisa, which collects 55% of the toll revenues. The company, which operates the largest road network in the country and has an average of nearly 25,000 vehicles per day, earns 750 million euros. Lusoponte follows in second place, with 650 million euros. (Photo by Luis Boza/NurPhoto via Getty Images) (Photo by Luis Boza/NurPhoto)